10-05-2021, 06:58 PM
(Última modificación: 10-05-2021, 07:04 PM por soulnmagic.)
Justo hoy colgué leyendo varios artículos. Parece que se viene una movida para emplear MDMA y hongos en tratamientos para pacientes que sufren estrés post-traumático. Sé que este fue el "origen" de la droga y que siempre estuvo dando vueltas la idea, pero me da la sensación de que esta vez es en serio.
"Before MDMA-assisted therapy can be approved for therapeutic use, the Food and Drug Administration needs a second positive Phase 3 trial, which is currently underway with 100 participants. Approval could come as early as 2023.
Mental health experts say that this research — the first Phase 3 trial conducted on psychedelic-assisted therapy — could pave the way for further studies on MDMA’s potential to help address other difficult-to-treat mental health conditions, including substance abuse, obsessive compulsive disorder, phobias, eating disorders, depression, end-of-life anxiety and social anxiety in autistic adults".
Fuente: https://www.nytimes.com/2021/05/03/healt...roval.html
"It is potentially the most significant innovation in mental health we've seen in decades," Mr Robb said.
Fuente: https://www.abc.net.au/news/2020-04-15/c...h/12147352
"The drug 3,4-methylenedioxymethamphetamine (MDMA) has been showing effectiveness when it is used in conjunction with therapy to treat post-traumatic stress disorder. The treatment is administered in an outpatient setting with a residential stay. There are currently phase-III trials for MDMA-assisted therapy being conducted, and MDMA was given a Breakthrough Therapy Designation by the FDA in 2017. This means that the FDA determined that MDMA treats a serious or life-threatening condition, and preliminary evidence shows that MDMA may cause substantial improvement over other approved therapies for PTSD".
Fuente: https://www.forbes.com/sites/stephaniesa...72f9e95ce0
Plus, charlita con un crack en el podcast de Jordan Peterson: https://www.youtube.com/watch?v=NGIP-3Q-...e=youtu.be
"Before MDMA-assisted therapy can be approved for therapeutic use, the Food and Drug Administration needs a second positive Phase 3 trial, which is currently underway with 100 participants. Approval could come as early as 2023.
Mental health experts say that this research — the first Phase 3 trial conducted on psychedelic-assisted therapy — could pave the way for further studies on MDMA’s potential to help address other difficult-to-treat mental health conditions, including substance abuse, obsessive compulsive disorder, phobias, eating disorders, depression, end-of-life anxiety and social anxiety in autistic adults".
Fuente: https://www.nytimes.com/2021/05/03/healt...roval.html
"It is potentially the most significant innovation in mental health we've seen in decades," Mr Robb said.
Fuente: https://www.abc.net.au/news/2020-04-15/c...h/12147352
"The drug 3,4-methylenedioxymethamphetamine (MDMA) has been showing effectiveness when it is used in conjunction with therapy to treat post-traumatic stress disorder. The treatment is administered in an outpatient setting with a residential stay. There are currently phase-III trials for MDMA-assisted therapy being conducted, and MDMA was given a Breakthrough Therapy Designation by the FDA in 2017. This means that the FDA determined that MDMA treats a serious or life-threatening condition, and preliminary evidence shows that MDMA may cause substantial improvement over other approved therapies for PTSD".
Fuente: https://www.forbes.com/sites/stephaniesa...72f9e95ce0
Plus, charlita con un crack en el podcast de Jordan Peterson: https://www.youtube.com/watch?v=NGIP-3Q-...e=youtu.be
![[-]](https://argenpills.org/images/collapse.png)